WO2002005827A3 - Use of natural products in cancer treatment - Google Patents
Use of natural products in cancer treatment Download PDFInfo
- Publication number
- WO2002005827A3 WO2002005827A3 PCT/GB2001/003150 GB0103150W WO0205827A3 WO 2002005827 A3 WO2002005827 A3 WO 2002005827A3 GB 0103150 W GB0103150 W GB 0103150W WO 0205827 A3 WO0205827 A3 WO 0205827A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cancer treatment
- natural products
- cancer
- isoflavones
- micronutrients
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 201000011510 cancer Diseases 0.000 title abstract 3
- 229930014626 natural product Natural products 0.000 title 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 abstract 1
- 102000004856 Lectins Human genes 0.000 abstract 1
- 108090001090 Lectins Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 abstract 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract 1
- 229960003237 betaine Drugs 0.000 abstract 1
- 235000021466 carotenoid Nutrition 0.000 abstract 1
- 150000001747 carotenoids Chemical class 0.000 abstract 1
- 238000002648 combination therapy Methods 0.000 abstract 1
- 229930003935 flavonoid Natural products 0.000 abstract 1
- 235000017173 flavonoids Nutrition 0.000 abstract 1
- 150000002215 flavonoids Chemical class 0.000 abstract 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 abstract 1
- 150000002515 isoflavone derivatives Chemical class 0.000 abstract 1
- 235000008696 isoflavones Nutrition 0.000 abstract 1
- 239000002523 lectin Substances 0.000 abstract 1
- 239000011785 micronutrient Substances 0.000 abstract 1
- 235000013369 micronutrients Nutrition 0.000 abstract 1
- 229910052711 selenium Inorganic materials 0.000 abstract 1
- 239000011669 selenium Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001276462A AU2001276462A1 (en) | 2000-07-18 | 2001-07-18 | Use of natural products in cancer treatment |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0017620.6 | 2000-07-18 | ||
GB0017620A GB0017620D0 (en) | 2000-07-18 | 2000-07-18 | Flavonoids in cancer treatment |
GB0023574.7 | 2000-09-26 | ||
GB0023574A GB0023574D0 (en) | 2000-09-26 | 2000-09-26 | Use of natural products in cancer treatment |
GB0026600.7 | 2000-10-31 | ||
GB0026600A GB0026600D0 (en) | 2000-10-31 | 2000-10-31 | Use of natural products in cancer treatment |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002005827A2 WO2002005827A2 (en) | 2002-01-24 |
WO2002005827A3 true WO2002005827A3 (en) | 2002-07-18 |
Family
ID=27255810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2001/003150 WO2002005827A2 (en) | 2000-07-18 | 2001-07-18 | Use of natural products in cancer treatment |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001276462A1 (en) |
WO (1) | WO2002005827A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2836046B1 (en) * | 2002-02-15 | 2006-09-15 | Marie Jose Touche | NOVEL THERAPEUTIC APPLICATION OF COMPOUND A: BUTOFORM OR SCUROFORM ASSOCIATED WITH PRODUCT B: EUGENOL AND PRODUCT C: ZINC OXIDE, ADDED TO LYCOPENE |
WO2003068202A1 (en) * | 2002-02-15 | 2003-08-21 | Dsm Ip Assets B.V. | Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies |
DE10310196A1 (en) * | 2003-03-06 | 2004-09-23 | Rina-Netzwerk Rna Technologien Gmbh | Use a tricyclic antidepressant to promote endocytosis |
US9597311B2 (en) * | 2005-09-27 | 2017-03-21 | Robert Benson Aylor | Suppression and prevention of tumors |
EP2260856A1 (en) | 2009-05-12 | 2010-12-15 | URSAPHARM Arzneimittel GmbH | Immune stimulating composition comprising an extract of aronia sp. in combination with selenium and/or zinc |
US9572783B1 (en) | 2015-10-08 | 2017-02-21 | Chuen Wei Lu | Use of xanthophylls for the treatment of cancers |
EP3153160B1 (en) * | 2015-10-08 | 2021-08-11 | Chuen Wei Lu | Use of xanthophylls for the treatment of cancers |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4111208A1 (en) * | 1991-04-06 | 1992-10-08 | Inge Witte | Plant extract for treating cancer - comprises Thuja soln., elder, beetroot, wheat germ oil, lacto- and soya protein and wild yeast |
EP0627173A1 (en) * | 1993-05-31 | 1994-12-07 | GIULIANI S.p.A. | Preparation for dietetic use or as a food supplement, with targeted release in the colon |
WO1995021542A1 (en) * | 1994-02-08 | 1995-08-17 | Vioryl Chemical And Agricultural Industry, Research S.A. | A natural and healthy juice |
WO1999007400A1 (en) * | 1997-08-06 | 1999-02-18 | Melaleuca, Incorporated | Dietary supplements containing natural ingredients |
US6103756A (en) * | 1999-08-11 | 2000-08-15 | Vitacost Inc. | Ocular orally ingested composition for prevention and treatment of individuals |
WO2001019383A1 (en) * | 1999-09-17 | 2001-03-22 | Alcon, Inc. | Stable carotene-xanthophyll beadlet compositions and methods of use |
WO2001085183A2 (en) * | 2000-05-08 | 2001-11-15 | N.V. Nutricia | Preparation for the prevention and treatment of ocular disorders |
-
2001
- 2001-07-18 WO PCT/GB2001/003150 patent/WO2002005827A2/en active Search and Examination
- 2001-07-18 AU AU2001276462A patent/AU2001276462A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4111208A1 (en) * | 1991-04-06 | 1992-10-08 | Inge Witte | Plant extract for treating cancer - comprises Thuja soln., elder, beetroot, wheat germ oil, lacto- and soya protein and wild yeast |
EP0627173A1 (en) * | 1993-05-31 | 1994-12-07 | GIULIANI S.p.A. | Preparation for dietetic use or as a food supplement, with targeted release in the colon |
WO1995021542A1 (en) * | 1994-02-08 | 1995-08-17 | Vioryl Chemical And Agricultural Industry, Research S.A. | A natural and healthy juice |
WO1999007400A1 (en) * | 1997-08-06 | 1999-02-18 | Melaleuca, Incorporated | Dietary supplements containing natural ingredients |
US6103756A (en) * | 1999-08-11 | 2000-08-15 | Vitacost Inc. | Ocular orally ingested composition for prevention and treatment of individuals |
WO2001019383A1 (en) * | 1999-09-17 | 2001-03-22 | Alcon, Inc. | Stable carotene-xanthophyll beadlet compositions and methods of use |
WO2001085183A2 (en) * | 2000-05-08 | 2001-11-15 | N.V. Nutricia | Preparation for the prevention and treatment of ocular disorders |
Non-Patent Citations (5)
Title |
---|
CARROLL K K ET AL: "ANTICANCER PROPERTIES OF FLAVONOIDS, WITH EMPHASIS ON CITRUS FLAVONOIDS", ANTIOXIDANTS IN HEALTH AND DISEASE, MARCEL DEKKER, NEW YORK, NY,, US, vol. 7, 1998, pages 437 - 446, XP000960909, ISSN: 1521-4486 * |
COMBS G F JR ET AL: "Reduction of cancer mortality and incidence by selenium supplementation", MEDIZINISCHE KLINIK, XX, XX, vol. 92, no. SUPPL 3, 1997, pages 42 - 45, XP002123911 * |
FRANKEL E N: "NUTRITIONAL BENEFITS OF FLAVONOIDS", FOOD FACTORS FOR CANCER PREVENTION, XX, XX, 1997, pages 613 - 616, XP000886654 * |
MOULY PIERRE P ET AL: "Determination of the geographical origin of valencia orange juice using carotenoid liquid chromatographic profiles.", JOURNAL OF CHROMATOGRAPHY A, vol. 844, no. 1-2, 4 June 1999 (1999-06-04), pages 149 - 159, XP004170302, ISSN: 0021-9673 * |
SO F V ET AL: "INHIBITION OF HUMAN BREAST CANCER CELL PROLIFERATION AND DELAY OF MAMMARY TUMORIGENESIS BY FLAVONOIDS AND CITRUS JUICES", NUTRITION AND CANCER, LONDON, GB, vol. 26, no. 2, 1996, pages 167 - 181, XP000938970, ISSN: 0163-5581 * |
Also Published As
Publication number | Publication date |
---|---|
AU2001276462A1 (en) | 2002-01-30 |
WO2002005827A2 (en) | 2002-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004005326A3 (en) | Tubulysin conjugates | |
WO2003055527A3 (en) | Immunoconjugates useful for treatment of tumours | |
HUP0400231A3 (en) | Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer | |
HK1102544A1 (en) | Use of herbal compositions in the manufacture of medicine for treating prostate cancer | |
EP1355563A4 (en) | METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES | |
AU2001282717A1 (en) | Cancer treatment by combination therapy | |
EP1816996A4 (en) | Methods and therapeutic compositions comprising plant extracts for the treatment of cancer | |
WO2001092581A8 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
AU2003273182A1 (en) | Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases | |
WO2004080284A3 (en) | Antibody-targeted photodynamic therapy | |
WO2002005827A3 (en) | Use of natural products in cancer treatment | |
IL158206A0 (en) | Compositions and methods for the prevention and treatment of human prostate cancer | |
WO2004073615A3 (en) | Deazaflavin compounds and methods of use thereof | |
WO2000013712A3 (en) | Methods and compositions for the prevention or treatment of cancer | |
WO2003013560A1 (en) | Herbal composition for treatment of chronic renal failure and method to produce thereof | |
WO2002039885A3 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
WO2002087604A3 (en) | Preparations containing a combination of vitamin e and afamin | |
EP1234585A3 (en) | Methods and compositions for the prevention or treatment of cancer | |
WO1999034785A3 (en) | Treatment of dyskinesias | |
WO2001091771A3 (en) | Compositions for treating back and leg discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins | |
WO2002024179A3 (en) | Method for reducing toxicity of combined chemotherapies | |
AU2002246308A1 (en) | Herbal formulation for treating attention defienciency disorder (add/adht) and process for preparation | |
EP1583543A4 (en) | Methods and therapeutic compositions in the treatment of advanced cancer | |
NZ501641A (en) | Ganglioside immunostimulating complexes and their use in treating cancer | |
AU2003280341A1 (en) | Synergistic combinations of dietary fiber and n-saids for the treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: JP |